The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis
Authors:
- 28 September 2023
- journal article
- review article
- Published by Springer Nature in Annals of Hematology
- Vol. 102 (12) , 3555-3566
Abstract
Growing evidence suggests that highly intestinal microbiota diversity modulates host inflammation and promotes immune tolerance. Several studies have reported that patients undergoing allo-HSCT have experienced microbiota disruption that is characterized by expansion of potentially pathogenic bacteria and loss of microbiota diversity. Thus, the primary aim of this meta-analysis was to determine the association of intestinal microbiota diversity and outcomes after allo-HSCT, and the secondary aim was to analyze the associations of some specific microbiota abundances with the outcomes of allo-HSCT. Electronic databases of Pubmed, Embase, Web of Science, and Cochrane Library were searched from inception to August 2023, and 17 studies were found eligible. The pooled estimate suggested that higher intestinal microbiota diversity was significantly associated with overall survival (OS) benefit (HR = 0.66, 95% CI: 0.55–0.78), as well as decreased risk of transplant-related mortality (HR = 0.56, 95% CI: 0.41–0.76), and lower incidence of grade II-IV aGVHD (HR = 0.41, 95% CI: 0.27–0.63). Furthermore, higher abundance of Clostridiales was associated with a superior OS (HR = 0.40, 95% CI: 0.18–0.87), while higher abundance of Enterococcus (HR = 2.03, 95% CI: 1.55–2.65), γ-proteobacteria (HR = 2.82, 95% CI: 1.53–5.20), and Candida (HR = 3.80, 95% CI: 1.32–10.94) was an adverse prognostic factor for OS. Overall, this meta-analysis highlights the protective role of higher intestinal microbiota diversity on outcomes after allo-HSCT during both pre-transplant and post-transplant periods. Some specific microbiota can be useful in the identification of patients at risk of mortality, offering new tools for individualized pre-emptive or therapeutic strategies to improve allo-HSCT outcomes.Keywords
Funding Information
- National Natural Science Foundation of China (82100123, 82170141, 81870136)
- Natural Science Foundation of Zhejiang Province (LXZ22H080001)
This publication has 61 references indexed in Scilit:
- Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcomeBlood, 2015
- Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2015
- The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantationBlood, 2014
- Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2014
- Role of the Microbiota in Immunity and InflammationCell, 2014
- Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated DonorsNew England Journal of Medicine, 2012
- Extending DerSimonian and Laird's methodology to perform multivariate random effects meta‐analysesStatistics in Medicine, 2010
- Graft-versus-host diseaseThe Lancet, 2009
- Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipientsBone Marrow Transplantation, 2007
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007